Basic Information
| RNALocate ID: | RLID:02000504 |
| RNA Symbol: | MALAT1 |
| Localization: | Mitochondrion |
RNA Information
| RNA Name: | MALAT1 |
| RNA ID: | NCBI:378938|Ensembl:ENSG00000251562 |
| RNA Category: | lncRNA |
| Species: | Homo sapiens |
| Alias: | HCN|LINC00047|NCRNA00047|NEAT2|PRO2853 |
Localization Information
| PubMed ID: | 31218107 |
| Tissue/Cell Line: | HCC cell line (HepG2) |
| Method: | RNA FISH |
|
RNA-FISH of MALAT1 in isolated HepG2 mitochondria. MALAT1 is localized in the isolated mitochondria that are stained in red with the MitoTracker dye. Originally published in Am J Cancer Res. Zhao Y, et al, 2019. Reproduced under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) |
|
| Description: | Thus, we isolated mitochondria and performed RNA-FISH on smear slides. We found that the probe enriched area (green) coincided with that of the MitoTracker staining (Figure 4A). Thus, MALAT1, although encoded by the nuclear genome, was also enriched in the mitochondria collected from HepG2 cells. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:02000386 | Nucleus | ZFL cells | 28538188 |
| RLID:02000501 | Chromatin | Breast cancer cell line (SKBR3) | 28652379 |
| RLID:02000502 | Cytoplasm | HEK-293T cells|Mammary epithelium cell line (HC11) | 31863590 |
| RLID:02000503 | Cytosol | Human myelogenous leukemia cell line (K-562) | 21613539 |
| RLID:02000505 | Nucleus | Human osteosarcoma cell line (U2OS) | 28423669 |
| RLID:02000506 | Nucleus | HeLa cells | 28663102 |
| RLID:02000507 | Nucleus | WI-38 cells | 29133588 |
| RLID:02000508 | Nucleus | Human brain microvascular endothelial cells | 30419554 |
| RLID:02000509 | Nuclear speckle | Breast cancer cell line (MCF-7) | 28652379 |
| RLID:02000510 | Nuclear speckle | Retinal microvascular endothelial cells | 30815547 |
| RLID:02000511 | Nuclear speckle | U2OS cells | 31085639 |
| RLID:02000512 | Nuclear speckle | HEK-293T cells|Mammary epithelium cell line (HC11) | 31863590 |
| RLID:02000513 | Nuclear speckle | HeLa-TO cells | 22355166 |
| RLID:02000514 | Nucleoplasm | WI-38 cells | 29133588 |
| RLID:02000515 | Nucleus | Human cervical cancer cell line (HeLa) | 28216671 |
| RLID:02000516 | Nucleus | U2OS cells | 28538188 |
| RLID:02000517 | Nucleus | Breast cancer cell lines (MDA-MB-468|SKBR3) | 28652379 |
| RLID:02000518 | Nucleus | HeLa cells | 29335281 |
| RLID:02000519 | Nucleus | Lung cancer cell line (A549) | 30548064 |
| RLID:02000520 | Nucleus | Vascular smooth muscle cells | 31696492 |
| RLID:02000521 | Nucleus | Fibroblasts|Lymphoblasts | 17270048 |
| RLID:02000522 | Nucleus | Cell line (HeLa) | 19041754 |
| RLID:02000523 | Nucleus | HeLa cells | 20797886 |
| RLID:02000524 | Nucleus | Motor neurons | 22070123 |
| RLID:02000525 | Nucleus | Human cervical cancer cell line (HeLa) | 22078878 |
| RLID:02000526 | Nucleus | CLTon cells | 22855529 |
| RLID:02000527 | Nucleus | HeLa cells | 23073843 |
| RLID:02000528 | Nucleus | Cell line (HeLa) | 23152763 |
| RLID:02000529 | Nucleus | Colon cancer cells | 24393600 |
| RLID:02000530 | Nucleus | HeLa cells | 25630241 |
| RLID:02001011 | Nucleus | IgH-2 cells|Periphery of seminiferous tubules | 28538188 |
| RLID:02001145 | Cytoplasm | Lung cancer cell lines (A549|H1299) | 34012919 |
| RLID:12000064 | Exosome | Thyroid papillary carcinoma cell line (TPC-1) | 29967342 |
| RLID:12000065 | Exosome | HeLa cells | 24205503 |
| RLID:22000052 | Speckle periphery | HeLa cells|WI-38 cells | 29133588 |
| RLID-D:02000317 | Chromatin | HeLa-S3 cells|K562 cells | |
| RLID-D:02000618 | Cytosol | HCC cell line (HepG2)|HeLa-S3 cells|K562 cells | |
| RLID-D:02000717 | Insoluble cytoplasm | K562 cells | |
| RLID-D:02000824 | Membrane | HCC cell line (HepG2)|K562 cells | |
| RLID-D:02001085 | Nucleolus | K562 cells | |
| RLID-D:02001487 | Nucleoplasm | K562 cells | |
| RLID-D:02002025 | Nucleus | HCC cell line (HepG2)|HeLa-S3 cells|K562 cells | |
| RLID-D:12004468 | Exosome | Serum |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | MALAT1 | Anaplastic large cell lymphoma | MNDR-E-LNC-17626 |
| MNDR | MALAT1 | Diffuse large b cell lymphoma | MNDR-E-LNC-17627 |
| MNDR | MALAT1 | Mantle cell lymphoma | MNDR-E-LNC-17628 |
| MNDR | MALAT1 | Oral tongue squamous cell carcinoma | MNDR-E-LNC-17629 |
| MNDR | MALAT1 | Oral squamous cell carcinoma | MNDR-E-LNC-17630 |
| MNDR | MALAT1 | Fibroma | MNDR-E-LNC-17631 |
| MNDR | MALAT1 | Triple negative breast cancer | MNDR-E-LNC-17632 |
| MNDR | MALAT1 | Nonalcoholic fatty liver disease | MNDR-E-LNC-17633 |
| MNDR | MALAT1 | Anaplastic thyroid cancer | MNDR-E-LNC-17634 |
| MNDR | MALAT1 | Prostate cancer | MNDR-E-LNC-17635 |
| MNDR | MALAT1 | Silicosis | MNDR-E-LNC-17636 |
| MNDR | MALAT1 | Chronic lymphocytic leukemia | MNDR-E-LNC-17637 |
| MNDR | MALAT1 | Gastric cancer | MNDR-E-LNC-17638 |
| MNDR | MALAT1 | Pre-eclampsia | MNDR-E-LNC-17639 |
| MNDR | MALAT1 | Alzheimer disease | MNDR-E-LNC-17640 |
| MNDR | MALAT1 | Bladder cancer | MNDR-E-LNC-17641 |
| MNDR | MALAT1 | Gestational diabetes | MNDR-E-LNC-17642 |
| MNDR | MALAT1 | Seizures | MNDR-E-LNC-17643 |
| MNDR | MALAT1 | Lung cancer | MNDR-E-LNC-17644 |
| MNDR | MALAT1 | Diabetic cataract | MNDR-E-LNC-17645 |
| MNDR | MALAT1 | Parkinson disease | MNDR-E-LNC-17646 |
| MNDR | MALAT1 | Primary pulmonary hypertension | MNDR-E-LNC-17647 |
| MNDR | MALAT1 | Breast cancer | MNDR-E-LNC-17648 |
| MNDR | MALAT1 | Cancer | MNDR-E-LNC-17649 |
| MNDR | MALAT1 | Squamous cell carcinoma | MNDR-E-LNC-17650 |
| MNDR | MALAT1 | Thyroid cancer | MNDR-E-LNC-17651 |
| MNDR | MALAT1 | Pancreatic cancer | MNDR-E-LNC-17652 |
| MNDR | MALAT1 | Malignant melanoma | MNDR-E-LNC-17653 |
| MNDR | MALAT1 | Atherosclerosis | MNDR-E-LNC-17654 |
| MNDR | MALAT1 | Vulva squamous cell carcinoma | MNDR-E-LNC-17655 |
| MNDR | MALAT1 | Epithelial ovarian cancer | MNDR-E-LNC-17656 |
| MNDR | MALAT1 | Colon cancer | MNDR-E-LNC-17657 |
| MNDR | MALAT1 | Hepatitis | MNDR-E-LNC-17658 |
| MNDR | MALAT1 | Ovarian cancer | MNDR-E-LNC-17659 |
| MNDR | MALAT1 | Laryngeal and hypopharyngeal carcinoma | MNDR-E-LNC-17660 |
| MNDR | MALAT1 | Kidney cancer | MNDR-E-LNC-17661 |
| MNDR | MALAT1 | Urothelial cancer | MNDR-E-LNC-17662 |
| MNDR | MALAT1 | Infantile hemangioma | MNDR-E-LNC-17663 |
| MNDR | MALAT1 | Carcinoma endometrioid | MNDR-E-LNC-17664 |
| MNDR | MALAT1 | Endometrial carcinoma | MNDR-E-LNC-17665 |
| MNDR | MALAT1 | Laryngeal squamous cell cancer | MNDR-E-LNC-17666 |
| MNDR | MALAT1 | Endometriosis | MNDR-E-LNC-17667 |
| MNDR | MALAT1 | DH1/2 wild-type primary GB tumor | MNDR-E-LNC-17668 |
| MNDR | MALAT1 | Astrocytoma | MNDR-E-LNC-17669 |
| MNDR | MALAT1 | Glioma | MNDR-E-LNC-17670 |
| MNDR | MALAT1 | Gastrointestinal system cancer | MNDR-E-LNC-17671 |
| MNDR | MALAT1 | Gallbladder cancer | MNDR-E-LNC-17672 |
| MNDR | MALAT1 | Skin squamous cell carcinoma | MNDR-E-LNC-17673 |
| MNDR | MALAT1 | Amyotrophic lateral sclerosis | MNDR-E-LNC-17674 |
| MNDR | MALAT1 | Osteosarcoma | MNDR-E-LNC-17675 |
| MNDR | MALAT1 | Fibrosarcoma | MNDR-E-LNC-17676 |
| MNDR | MALAT1 | Ewing sarcoma | MNDR-E-LNC-17677 |
| MNDR | MALAT1 | Pancreatic ductal adenocarcinoma | MNDR-E-LNC-17678 |
| MNDR | MALAT1 | Liver cancer | MNDR-E-LNC-17679 |
| MNDR | MALAT1 | Choriocarcinoma | MNDR-E-LNC-17680 |
| MNDR | MALAT1 | Uterine cancer | MNDR-E-LNC-17681 |
| MNDR | MALAT1 | Gastric adenocarcinoma | MNDR-E-LNC-17682 |
| MNDR | MALAT1 | Esophagus squamous cell carcinoma | MNDR-E-LNC-17683 |
| MNDR | MALAT1 | Pulmonary fibrosis | MNDR-E-LNC-17684 |
| MNDR | MALAT1 | Pituitary adenoma | MNDR-E-LNC-17685 |
| MNDR | MALAT1 | Lung squamous cell carcinoma | MNDR-E-LNC-17686 |
| MNDR | MALAT1 | Carcinoma lung non-small-cell | MNDR-E-LNC-17687 |
| MNDR | MALAT1 | Lung adenocarcinoma | MNDR-E-LNC-17688 |
| MNDR | MALAT1 | Adrenocortical carcinoma | MNDR-E-LNC-17689 |
| MNDR | MALAT1 | Follicular thyroid carcinoma | MNDR-E-LNC-17690 |
| MNDR | MALAT1 | Papillary thyroid cancer | MNDR-E-LNC-17691 |
| MNDR | MALAT1 | Medullary thyroid carcinoma | MNDR-E-LNC-17692 |
| MNDR | MALAT1 | Thyroid medullary carcinoma | MNDR-E-LNC-17693 |
| MNDR | MALAT1 | Ovarian carcinoma | MNDR-E-LNC-17694 |
| MNDR | MALAT1 | Bladder urothelial carcinoma | MNDR-E-LNC-17695 |
| MNDR | MALAT1 | Bladder carcinoma | MNDR-E-LNC-17696 |
| MNDR | MALAT1 | Hyperglycemia | MNDR-E-LNC-17697 |
| MNDR | MALAT1 | Endometrial stromal sarcoma | MNDR-E-LNC-17698 |
| MNDR | MALAT1 | Uterine corpus endometrial stromal sarcoma | MNDR-E-LNC-17699 |
| MNDR | MALAT1 | Cervical cancer | MNDR-E-LNC-17700 |
| MNDR | MALAT1 | Renal cell carcinoma | MNDR-E-LNC-17701 |
| MNDR | MALAT1 | Clear cell renal cell carcinoma | MNDR-E-LNC-17702 |
| MNDR | MALAT1 | Histiocytoid hemangioma | MNDR-E-LNC-17703 |
| MNDR | MALAT1 | Gorham's disease | MNDR-E-LNC-17704 |
| MNDR | MALAT1 | Pancreatic carcinoma | MNDR-E-LNC-17705 |
| MNDR | MALAT1 | Hilar cholangiocarcinoma | MNDR-E-LNC-17706 |
| MNDR | MALAT1 | Cholangiocarcinoma | MNDR-E-LNC-17707 |
| MNDR | MALAT1 | Esophageal cancer | MNDR-E-LNC-17708 |
| MNDR | MALAT1 | Liver cirrhosis | MNDR-E-LNC-17709 |
| MNDR | MALAT1 | HIV | MNDR-E-LNC-17710 |
| MNDR | MALAT1 | Lung small cell carcinoma | MNDR-E-LNC-17711 |
| MNDR | MALAT1 | Head and neck squamous cell carcinoma | MNDR-E-LNC-17712 |
| MNDR | MALAT1 | Kidney diseases | MNDR-E-LNC-17713 |
| MNDR | MALAT1 | Myocardial infarction | MNDR-E-LNC-17714 |
| MNDR | MALAT1 | Uveal melanoma | MNDR-E-LNC-17715 |
| MNDR | MALAT1 | Aortic valve disease | MNDR-E-LNC-17716 |
| MNDR | MALAT1 | Ovarian endometrial cancer | MNDR-E-LNC-17717 |
| MNDR | MALAT1 | Acute monocytic leukemia | MNDR-E-LNC-17718 |
| MNDR | MALAT1 | Bladder transitional cell carcinoma | MNDR-E-LNC-17719 |
| MNDR | MALAT1 | Ischemic stroke | MNDR-E-LNC-17720 |
| MNDR | MALAT1 | Endometrioid endometrial cancer | MNDR-E-LNC-17721 |
| MNDR | MALAT1 | Hepatocellular carcinoma | MNDR-E-LNC-17722 |
| MNDR | MALAT1 | Hepatoblastoma | MNDR-E-LNC-17723 |
| MNDR | MALAT1 | B-cell lymphoma | MNDR-E-LNC-17724 |
| MNDR | MALAT1 | Rheumatoid arthritis | MNDR-E-LNC-17725 |
| MNDR | MALAT1 | Retinoblastoma | MNDR-E-LNC-17726 |
| MNDR | MALAT1 | Neuroblastoma | MNDR-E-LNC-17727 |
| MNDR | MALAT1 | Osteoarthritis | MNDR-E-LNC-17728 |
| MNDR | MALAT1 | Retinal degeneration | MNDR-E-LNC-17729 |
| MNDR | MALAT1 | Monocytic leukemia | MNDR-E-LNC-17730 |
| MNDR | MALAT1 | Chronic myeloid leukemia | MNDR-E-LNC-17731 |
| MNDR | MALAT1 | Tongue cancer | MNDR-E-LNC-17732 |
| MNDR | MALAT1 | Diabetic retinopathy | MNDR-E-LNC-17733 |
| MNDR | MALAT1 | Systemic lupus erythematosus | MNDR-E-LNC-17734 |
| MNDR | MALAT1 | Acute myeloid leukemia | MNDR-E-LNC-17735 |
| MNDR | MALAT1 | Colorectal cancer | MNDR-E-LNC-17736 |
| MNDR | MALAT1 | Nasopharyngeal carcinoma | MNDR-E-LNC-17737 |
| MNDR | MALAT1 | Nasopharynx carcinoma | MNDR-E-LNC-17738 |
| MNDR | MALAT1 | Diabetes mellitus | MNDR-E-LNC-17739 |
| MNDR | MALAT1 | Type 2 diabetes mellitus | MNDR-E-LNC-17740 |
| MNDR | MALAT1 | Acute myocardial infarction | MNDR-E-LNC-17741 |
| MNDR | MALAT1 | Fatty liver disease | MNDR-E-LNC-17742 |
| MNDR | MALAT1 | Multiple myeloma | MNDR-E-LNC-17743 |
| MNDR | MALAT1 | Extramedullary myeloma | MNDR-E-LNC-17744 |
| MNDR | MALAT1 | Proliferative vitreoretinopathy | MNDR-E-LNC-17745 |
| MNDR | MALAT1 | TDP-43 protein human | MNDR-E-LNC-17746 |
| MNDR | MALAT1 | Aortic valve calcification | MNDR-E-LNC-17747 |
| MNDR | MALAT1 | Ovarian epithelial cancer | MNDR-E-LNC-17748 |
| MNDR | MALAT1 | Esophageal squamous cancer | MNDR-E-LNC-17749 |
| MNDR | MALAT1 | Bronchopulmonary dysplasia | MNDR-E-LNC-17750 |
| MNDR | MALAT1 | Uterine cervical neoplasms | MNDR-E-LNC-17751 |
| MNDR | MALAT1 | Diabetic nephropathies | MNDR-E-LNC-17752 |
| MNDR | MALAT1 | Nasopharyngeal cancer | MNDR-E-LNC-17753 |
| MNDR | MALAT1 | Prostate | MNDR-E-LNC-17754 |
| MNDR | MALAT1 | Spinal cord injury | MNDR-E-LNC-17755 |
| MNDR | MALAT1 | Flavivirus infections | MNDR-E-LNC-17756 |
| MNDR | MALAT1 | Sepsis | MNDR-E-LNC-17757 |
| MNDR | MALAT1 | Nk/t cell lymphoma | MNDR-E-LNC-17758 |
| MNDR | MALAT1 | Acute lung injury | MNDR-E-LNC-17759 |
| MNDR | MALAT1 | Diabetic cardiomyopathies | MNDR-E-LNC-17760 |
| MNDR | MALAT1 | Congenital microtia | MNDR-E-LNC-17761 |
| MNDR | MALAT1 | Calcific aortic valve disease | MNDR-E-LNC-17762 |
| MNDR | MALAT1 | Cardiomyocyte apoptosis | MNDR-E-LNC-17763 |
| MNDR | MALAT1 | Cerebral ischemia-reperfusion injury | MNDR-E-LNC-17764 |
| MNDR | MALAT1 | Cutaneous squamous cell carcinoma | MNDR-E-LNC-17765 |
| MNDR | MALAT1 | Decreased myogenesis | MNDR-E-LNC-17766 |
| MNDR | MALAT1 | EndMT-related diseases | MNDR-E-LNC-17767 |
| MNDR | MALAT1 | High glucose-induced podocyte injury | MNDR-E-LNC-17768 |
| MNDR | MALAT1 | Lymph node metastasis | MNDR-E-LNC-17769 |
| MNDR | MALAT1 | Photo-aging | MNDR-E-LNC-17770 |
| MNDR | MALAT1 | Plexiform fibromyxoma | MNDR-E-LNC-17771 |
| MNDR | MALAT1 | Renal ischemia-reperfusion injury | MNDR-E-LNC-17772 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCA1 | Homo sapiens | RR00022040 |
TOP